Sponsored by Open Therapeutics. Matching funds are being sought. Details coming soon...
New development of oHSV for cancer treatment
Sponsored by: Open Therapeutics™
This grant will award up to $3,000.00 towards the winning proposal(s).
Proposals that utilize the following Technologies will be considered: oncolytic herpes simplex virus (oHSV)-rQT3 against cancer cells
From 2018-09-01 22:00 UTC to 2018-10-01 22:00 UTC